The end-of-life hospital setting in patients with glioblastoma.
Despite aggressive treatment, outcome of patients with glioblastoma is poor. Several distinct clinical problems arise in the terminal stage of this disease. The purpose of this study was to evaluate the end-of-life phase in a hospital setting in patients with glioblastoma. Twenty-nine consecutive patients with glioblastoma, who died in our department, were included in this analysis regarding symptoms, medication, diagnostics, and interventional procedures. The patients were comparable with respect to age, gender, and overall survival with data from the literature. Relevant clinical symptoms, medications, diagnostics, well as interventional procedures increased continuously toward end of life. Pain, epileptic seizures, and symptoms of brain edema were the most frequent clinical symptoms. According to this, most patients were on antiepileptic drugs (AED), steroids, and analgesics. In the last phase, symptoms from brain edema, fever, decrease of vigilance, dysphagia, and pneumonia were the prominent clinical features. Our study demonstrates that the end of life in patients with glioblastoma has several periods with different clinical aspects with respect to symptoms and treatment.
Oberndorfer
Stefan
S
Ludwig Boltzmann Institute for Neurooncology, Department of Neurology, KFJ-Hospital-SMZ-SUD, Vienna, Austria.
Lindeck-Pozza
Elisabeth
E
Lahrmann
Heinz
H
Struhal
Walter
W
Hitzenberger
Peter
P
Grisold
Wolfgang
W
D000368:Aged; D001317:Austria / Q000453:epidemiology; D005260:Female; D005909:Glioblastoma / Q000188:drug therapy / Q000503:physiopathology* / Q000532:radiotherapy; D006761:Hospitals; D006801:Humans; D007297:Inpatients; D008297:Male; D008485:Medical Audit; D008875:Middle Aged; D010166:Palliative Care; D012189:Retrospective Studies; D013727:Terminal Care / Q000379:methods; D019452:Terminally Ill